New SEC Form D filing
NurExone Biologic Inc., 2026-08-21
A new SEC Form D private-offering notice from Technion City, Haifa, a $450,456 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
NurExone Biologic Inc. Verified via SEC Form D
Filed 2026-08-21Filed to raise $450,456First money in 2026-08-20Raised so far $450,456HQ (as filed) Technion City, HaifaSector Biotech machine-classified from the filing aloneStage (inferred) Pre-seedCall status Non-US principal office
Source linked the Form D on EDGAR↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- NewcelX Ltd., 2026-08-24, $2.9M, Kloten
- Citrachem Corp., 2026-08-21, $500K, Norwood, MA
- Outer Biosciences Inc, 2026-08-21, $23.3M, Malden, MA
- LifeCyte Innovations, Inc., 2026-08-20, $5M, Greensboro, GA
- Sentonix, Inc., 2026-08-20, $21.2M, Arlington, MA
- AMPLIFICA HOLDINGS GROUP, INC., 2026-08-20, $25M, San Diego, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.